Thiogenesis Announces Commencement of OTCQX Trading in the U.S.
Portfolio Pulse from
Thiogenesis Therapeutics, a clinical-stage biotechnology company, has announced that its common shares are now trading on the OTCQX Best Market under the ticker symbol TTIPF. This move marks an important step for the company as it seeks to expand its presence in the U.S. market.
February 12, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thiogenesis Therapeutics has started trading on the OTCQX Best Market, which could increase its visibility and attract more investors in the U.S.
Trading on the OTCQX Best Market is a positive development for Thiogenesis as it provides greater visibility and access to U.S. investors. This could lead to increased trading volume and potentially a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100